Beryl Drugs Promoter Acquires 7,500 Shares On-Market

Beryl Drugs Limited filed a SEBI Regulation 7(2) insider trading continual disclosure on 25 March 2026.
Promoter & Director Sudhir Sethi (DIN: 00090172) acquired 7,500 equity shares (0.14%) on-market on 24 March 2026.
Post-acquisition, Sudhir Sethi's holding in Beryl Drugs Limited increased to 4,93,983 shares (9.72%).